IDEAYA Biosciences, Inc. IDYA Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEAYA Biosciences, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IDEAYA Biosciences, Inc.'s financing cash flow?
- IDEAYA Biosciences, Inc. (IDYA) reported financing cash flow of $1.18M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s financing cash flow changed year-over-year?
- IDEAYA Biosciences, Inc.'s financing cash flow decreased by 95.5% year-over-year, from $26.14M to $1.18M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), IDEAYA Biosciences, Inc.'s financing cash flow has grown at a -32.7% compound annual growth rate (CAGR), from $145.45M to $29.78M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.